Sat, Apr 19, 2014, 9:28 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • stds42 stds42 Jul 2, 2012 3:42 PM Flag

    Adam, a thought provoking entertainer

    Over the years I've enjoyed reading all of Adam's articles because they are entertaining and thought provoking. I read his most recent Ampio article, I totally agree with him the end of the lock-up period is a factor for any investor to consider, especially traders. The rest of the article is pure entertainment, and pathetic. I e-mailed Adam and asked him why Ampio's compounds are "highly speculative", and what market cap would he give Ampio today? I'm waiting for a reply. Adam knows less about Ampio than he does about writing. Ampio IS DMI. DMI's three lead products are reconstituted compounds previously approved by the FDA for other indications. Not "highly speculative" as Adam states. DMI has patents on at leaast 25 other compounds, not to mention the immense potential for their diagnostic products. The man behind Ampio/DMI is Dr. David Bar-Or, he is brilliant. He has 30 years emergency room experience. He heads two level one trauma centers in the Denver area. Dr. Bar-Or is the real deal and so are Ampio/DMI's compounds and patents. Long term investors (5-10 years out) will thank the day they bought Ampio shares, those who didn't buy will understand Adam is a thought provoking, well paid entertainer.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMPE
5.44-0.08(-1.45%)Apr 17 4:07 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST